Effects of AF64A on gene expression of choline acetyltransferase (ChAT) in the septo-hippocampal pathway and striatum in vivo

Neurochemical Research

Volumn 24, Issue 1, 1999, Pages 15-24

  Fan, Qing Ivy ^a   Hanin, Israel ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

AF64A; Choline acetyltransferase; Cholinergic septo hippocampal pathway; Messenger RNA; Striatum

Indexed keywords

CHLORMETHINE; CHOLINE ACETYLTRANSFERASE; ETHYLCHOLINE MUSTARD AZIRIDINIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; LATERAL BRAIN VENTRICLE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA TRANSCRIPTION; STEREOTAXIC SURGERY; TARGET CELL;

ANIMALS; AZIRIDINES; BASE SEQUENCE; CEREBRAL VENTRICLES; CHOLINE; CHOLINE O-ACETYLTRANSFERASE; CORPUS STRIATUM; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INFUSIONS, PARENTERAL; MODELS, NEUROLOGICAL; MOLECULAR SEQUENCE DATA; NEURAL PATHWAYS; NEUROMUSCULAR BLOCKING AGENTS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEPTUM PELLUCIDUM; TRANSCRIPTION, GENETIC;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0032904333     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020967711189     Document Type: Article

References (52)

1. Hanin, I. 1994. The centrally cholino-deficient animal as a model of Alzheimer's disease (AD). Pages 67-374, in Giacobini, E., and Becker, R. (eds.), Alzheimer Disease: Therapeutic Strategies, Boston: Birkhauser.
2. Hanin, I. 1996. The AF64A model of cholinergic hypofunction: an update. Life Sci. 58:1955-1964.
3. El Tamer, A., Corey, J., Wülfert, E., and Hanin. I. 1992. Reversible cholinergic changes induced by AF64A in rat hippocampus and possible septal compensatory effect. Neuropharmacology 31:397-402.
4. Fisher, A., Mantione, C. R., Abraham, D. J., and Hanin, I. 1982. Long term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo. J. Pharmacol. Exp. Ther. 222:140-145.
5. Leventer, S. M., Wülfert, E., and I. Hanin. 1986. Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo. Neuropharmacology 26:361-365.
6. Chrobak, J. J., Hanin, I., and Walsh T. J. 1987. AF64A (ethylcholine aziridinium ion), a cholinergic neurotoxin, selectively impairs working memory in a multiple component T-maze task. Brain Res. 414:15-21.
7. Messer, W. S. Jr., Stibbe, J. R., and Bohnry, M. 1991. Involvement of the septohippocampal cholinergic system in representational memory. Brain Res. 564:66-72.
8. Mantione, C. R., Zigmond, M. J., Fisher, A., and Hanin I. 1983. Selective presynaptic cholinergic neurotoxicity following intrahippocampal AF64A injection in rats. J. Neurochem. 41:251-255.
9. Hörtnagl, H., Potter, P. E., and Hanin, I. 1987. Effect of cholinergic deficit induced by ethylcholine aziridinium (AF64A) on noradrenergic and dopaminergic parameters in rat brain. Brain Res. 421:75-84.
10. Kelley, M. C., Raizada, M. K., and Meyer, E. M. 1988. Pharmacological characterization of high affinity choline transporters in primary neuronal cultures in rat brain. Neuropharmacology 27(8):837-842.
11. Leventer, S. M., McKeag, D., Clancy, M., Wülfert, E., and Hanin, I. 1985. Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices. Neuropharmacology 24:453-459.
12. Tajima, T., Yoshimine, N., Goto, T., Ikari, H., Kuzuya, F., and Endo, H. 1993. Effects of intracerebroventricular administration of ethylcholine aziridinium ion on hippocampal cholinergic system, assayed in vivo by a brain dialysis technique, and on spatial memory of rats. Drug Develop. Res. 28:80-86.
13. Curti, D., and Marchbanks, R. M. 1982. Kinetics of irreversible inhibition of choline transport in synaptosomes by ethylcholine mustard aziridinium. J. Membr. Biol. 82:259-268.
14. Uney, J. B., and Marchbanks, R. M. 1987. Specificity of ethylcholine mustard aziridinium as an irreversible inhibitor of choline transport in cholinergic and noncholinergic tissue. J. Neurochem. 48:1673-1676.
15. Chrobak, J. J., Hanin, I., Schmechel, D. E., and Walsh, T. J. 1988. AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates. Brain Res. 463:107-117.
16. Baskey, J. C., Colhoun, E. H., and Rylett, R. J. 1990. Cholinergic but not GABAergic neuronal markers are decreased in primary neuronal cultures treated with choline mustard. Brain Res. 519:209-216.
17. Gomez, C., Martin, C., Galea, E., and Estrada C. 1993. Direct cytotoxicity of ethylcholine mustard aziridinium in cerebral microvascular endothelial cells. J. Neurochem. 60:1534-2539.
18. Brake, W. G., and Pappas, B. A. 1994. Hemicholinium-3 (HC3) blocks the effects of ethylcholine mustard aziridinium (AF64A) in the developing rat. Brain Res. Dev. Brain Res. 83:298-293.
19. Santiago, L. R., Kroes, R. A., Erickson, L. C., and Hanin, I. 1994. Choline (Ch) and hemicholinium-3 (HC-3) protect against AF64A-induced changes in N-myc expression in the human neuroblastoma cell line (LA-N-2). Soc. Neurosci. Abstr. 19:1747.
20. Lawley, P. D., and Brookes, P. 1965. Molecular mechanism of the cytotoxic action of dysfunctional alkylating agents and of resistance to this action. Nature 206:480-483.
21. Futscher, B. W., Pieper, R. O., Barnes, D. M, Hanin, I., and Erickson, L. C. 1992. DNA-damaging and transcription-terminating lesions induced by AF64A in vitro. J. Neurochem. 58:1504-1509.
22. Hanin, I., Yaron, A., Ginzberg, D., and Soreq, H. 1995. The cholinotoxin AF64A differentially attenuates in vitro transcription of the human cholinesterase genes. Pages 339-346,in Hanin, I., Yoshida, M., and Fisher, A. (eds.), Alzheimer's and Parkinson's Diseases: Recent Developments, Plenum Press, New York.
23. Lev-Lehman, E., El-Tamer, A., Yaron, A., Grifman, M., Ginzberg, D., Hanin, I., and Soreq, H. 1994. Cholinotoxic effects on acetylcholinesterase gene expression are associated with brain-region specific alterations in G,C-rich transcripts. Brain Res. 661:75-82.
24. Santiago, L. R. 1995. The effect of AF64A on colony formation, ChAT activity, and gene expression in the LA-N-2, cholinergic human neuroblastoma cell line, LA-N-2. Ph D. Dissertation, Loyola University Chicago, Stritch School of Medicine.
25. Santiago, L. R., Erickson, L. C., and Hanin, I. 1998. AF64A-induced changes in N-myc expression in the LA-N-2 human neuroblastoma cell line are modulated by choline and hemicholinium-3. Neurochem. Res. 23:747-754.
26. Ibanez, C. F., Ernfors, P., and Persson, H. 1991. Developmental and regional expression of choline acetyltransferase mRNA in the rat central nervous system. J. Neurosci. Res. 29:163-171.
27. Holler, T., Berse, B., Cermak, J. M., Diebler, M. F., and Blusztajn, J. K. 1996. Differences in the developmental expression of the vesicular acetylcholine transporter and choline acetyltransferase in the rat brain. Neurosci. Lett. 212(2):107-110.
28. Wellman, S. E., Casano, P. J., Pilch, D. R., Marzluff, W. F., and Sittman D. B. 1987. Characterization of mouse H3.3-like histone genes. Gene 59:29-39.
29. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:265-267.
30. Fonnum, F. 1975. Rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24:407-409.
31. Chomczynski, P., and Sacchi, N. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
32. Brice, A., Breeard, B., Raynaud, B., Ansieau, S., Coppola, T., Weber, M. J., and Mallet, J. 1989. Complete sequence of a cDNA encoding an active rat choline acetyltransferase: a tool to investigate the plasticity of cholinergic phenotype expression. J. Neurosci. Res. 23:266-273.
33. Pittel, Z., Fisher, A., and Heldman, E. 1987. Reversible and irreversible inhibition of high-affinity choline transport caused by ethylcholine aziridinium ion. J. Neurochem. 49:68-474.
34. Sandberg, K., Schnaar, R. L., McKinney, M., Fisher, A., and Coyle, J. T. 1985. AF64A: An active site directed irreversible inhibitor of choline acetyltransferase. J. Neurochem. 44:439-445.
35. Kása, P., and Hanin, I. 1985. Ethylcholine mustard aziridinium blocks the axoplasmic transport of acetylcholinesterase in cholinergic nerve fibers of the rat. Histochemistry 83:343-345.
36. Pilar, A. M., Atterwill, C. K., Deane, R. and Prince, A. K. 1987. The stability of ethylcholine mustard azridinium (ECMA) in cerebrospinal fluid and culture media. Br. J. Pharmacol. 92 (suppl.):694.
37. Wenthold, R. J., and Mahler, H. R. 1975. Purification of rat brain choline acetyltransferase and an estimation if its half-life. J. Neurochem. 24:963-967.
38. Hersh, L. B. 1992. Induction of choline acetyltransferase in the neuroblastoma X glioma cell line NG108-15. Neurochem. Res. 17:1063-1067.
39. Butcher, L. L., and Woolf, N. J. 1986. Central cholinergic system: synopsis of anatomy and overview of physiology and pathology. Pages 73-86, in Scheibel, A. B. and Wechsler, A. F. (eds.), The Biological Substrates of Alzheimer's Disease. New York: Academic Press.
40. 3H]choline uptake in rat striatal synaptosomes. Brain Res. 62:5234-539.
41. Suszkiw, J. B., and Pilar, G. 1976. Selective localization of a high affinity choline uptake system and its role in ACh formation in cholinergic nerve terminals. J. Neurochem. 26:1133-1138.
42. Kuhar, M. J., and Murrin, L. C. 1978. Sodium-dependent, high affinity choline uptake. J. Neurochem. 30:15-21.
43. Cavicchioli, L., Flanigan, T. P., Dickson, J. G., Vantini, G., Toso, R. D., Fusco, U., Walsh, F. S., and Leon, A. 1991. Choline acetyltransferase messenger RNA expression in developing and adult rat brain: regulation by nerve growth factor. Mol. Brain Res. 9:319-325.
44. Morley, B. J., Spangler, K. M, Schneider, B. L., and Javel E. 1991. Selective degeneration of a putative cholinergic pathway in the chinchilla cochlea following infusion with ethylcholine aziridinium ion. Brain Res. 544:94-100
45. Smith, D. W., Mount, R. J. and Callahan J. W. 1989. Selective damage to cochlear efferents by the choline neurotoxin ethylcholine mustard aziridinium ion (AF64A) in the chinchilla. Hearing Res. 42:113-118.
46. 3H]acetylcholine synthesis after AF64A-treatment in primary, neuron-enriched, rat septal-hippocampal and striatal cultures. Brain Res. Dev. Brain Res. 74:51-56.
47. Tajima, Y., and Salvaterra, P. M. 1992. Positive and negative feedback regulation of choline acetyltransferase mRNA levels in Drosophila: a study using temperature-sensitive mutants and embryo cell cultures. Brain Res. Mol. Brain Res. 13:213-221.
48. Lorens, S. A., Kindel, G., Dong, X. W., Lee, J. M., and Hanin, I. 1991. Septal choline acetyltransferase immunoreactive neurons: dose-dependent effects of AF64A. Brain Res. Bull. 26:965-971.
49. Tonnaer, A. D. M., Lammers, A. J. J. C., Wieringa, J. H., and Steinbusch, H. W. M. 1986. Immunohistochemical evidence for degeneration of cholinergic neurons in the forebrain of the rat following injection of AF64A-picrylsulfonate into the dorsal hippocampus. Brain Res. 370:200-203.
50. Mouton, P. R., and Arendash, G. W. 1990. Atrophy of cholinergic neurons within the rat nucleus basalis magnocellularis following intracortical AF64A infusion. Neurosci. Lett. 111:52-57.
51. Kása, P., Szerdahelyi, P., Fisher, A., and Hanin, I. 1986. Histochemical and electronmicroscopic study of the brain of the AF64A-treated rat. Page 447-460, in Fisher, A., Hanin, I., and Lachman, C. (eds.), Alzheimer's and Parkinson's Diseases: Strategies for Research and Development. Plenum Press, New York.
52. Stephens, P. H., Tagari, P., and Cuello, A. C. 1986. Ethylcholine mustard aziridinium ion lesions of the rat cortex result in retrograde degeneration of basal forebrain cholinergic neurons: implications for animal models of neurodegenerative disease. Neurochem. Res. 12:613-618